| What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples NC Ware, MA Wyatt, JE Haberer, JM Baeten, A Kintu, C Psaros, S Safren, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (5), 463-468, 2012 | 303 | 2012 |
| Burden of non-communicable diseases from infectious causes in 2017: a modelling study MM Coates, A Kintu, N Gupta, EB Wroe, AJ Adler, GF Kwan, PH Park, ... The Lancet Global Health 8 (12), e1489-e1498, 2020 | 82 | 2020 |
| An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda C Psaros, JE Haberer, E Katabira, A Ronald, E Tumwesigye, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 66 (5), 522-529, 2014 | 75 | 2014 |
| Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results … O Ogbuagu, PJ Ruane, D Podzamczer, LC Salazar, K Henry, DM Asmuth, ... The Lancet HIV 8 (7), e397-e407, 2021 | 70 | 2021 |
| Concomitant herbal medicine and Antiretroviral Therapy (ART) use among HIV patients in Western Uganda: a cross-sectional analysis of magnitude and patterns of use, associated … SJ Lubinga, A Kintu, J Atuhaire, S Asiimwe AIDS care 24 (11), 1375-1383, 2012 | 67 | 2012 |
| Association between HIV and blood pressure in adults and role of body weight as a mediator: Cross‐sectional study in Uganda S Okello, P Ueda, M Kanyesigye, E Byaruhanga, A Kiyimba, G Amanyire, ... The Journal of Clinical Hypertension 19 (11), 1181-1191, 2017 | 38 | 2017 |
| Integrating care for non‐communicable diseases into routine HIV services: key considerations for policy design in sub‐Saharan Africa A Kintu, D Sando, S Okello, G Mutungi, D Guwatudde, NA Menzies, ... Journal of the International AIDS Society 23, e25508, 2020 | 33 | 2020 |
| Cost‐effectiveness analysis of integrating screening and treatment of selected non‐communicable diseases into HIV/AIDS treatment in Uganda D Sando, A Kintu, S Okello, PC Kawungezi, D Guwatudde, G Mutungi, ... Journal of the International AIDS Society 23, e25507, 2020 | 26 | 2020 |
| A comparison of all-cause and cause-specific mortality by household socioeconomic status across seven INDEPTH network health and demographic surveillance systems in sub-Saharan … MM Coates, M Kamanda, A Kintu, I Arikpo, A Chauque, MM Mengesha, ... Global health action 12 (1), 1608013, 2019 | 22 | 2019 |
| Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP) M Cespedes, M Das, JC Hojilla, J Blumenthal, K Mounzer, M Ramgopal, ... PloS one 17 (6), e0267780, 2022 | 19 | 2022 |
| Noncommunicable Disease (NCD) strategic plans in low-and lower-middle income Sub-Saharan Africa: framing and policy response C Boudreaux, C Noble, MM Coates, J Kelley, M Abanda, A Kintu, ... Global Health Action 13 (1), 1805165, 2020 | 17 | 2020 |
| Incidence and risk factors for overweight and obesity after initiation of antiretroviral therapy in Dar es Salaam, Tanzania A Kintu, E Liu, E Hertzmark, D Spiegelman, RM Zack, A Muya, D Sando, ... Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2018 | 17 | 2018 |
| Sexual relationships outside primary partnerships and abstinence are associated with lower adherence and adherence gaps: data from the Partners PrEP ancillary adherence study A Kintu, SE Hankinson, R Balasubramanian, K Ertel, E Tumwesigye, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (1), 36-43, 2015 | 8 | 2015 |
| Gender affirming hormones do not affect the exposure and efficacy of F/TDF or F/TAF for HIV preexposure prophylaxis: a subgroup analysis from the DISCOVER trial MS Cespedes, M Das, J Yager, M Prins, I Krznaric, J de Jong, D Xiao, ... Transgender health 9 (1), 46-52, 2024 | 7 | 2024 |
| Facilitating next‐generation pre‐exposure prophylaxis clinical trials using HIV recent infection assays: a consensus statement from the Forum HIV Prevention Trial Design Project N Parkin, F Gao, E Grebe, A Cutrell, M Das, D Donnell, A Duerr, ... Clinical Pharmacology & Therapeutics 114 (1), 29-40, 2023 | 7 | 2023 |
| & Bangsberg, DR (2012). What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis (PrEP) for HIV serodiscordant couples NC Ware, MA Wyatt, JE Haberer, JM Baeten, A Kintu, C Psaros Journal of acquired immune deficiency syndromes 59 (5), 1999 | 7 | 1999 |
| What’s love got to do with it? A theory of adherence to once-daily oral pre-exposure prophylaxis (PrEP) for HIV prevention derived from qualitative data among HIV … N Ware, M Wyatt, J Haberer, J Baeten, A Kintu J Acquir Immune Defic Syndr 59 (5), 463-8, 2012 | 5 | 2012 |
| Proximate and distal factors associated with the stall in the decline of adolescent pregnancy in Uganda C Mbabazi, A Kintu, JB Asiimwe, JS Ssekamatte, I Shah, D Canning BMC Public Health 21, 1-13, 2021 | 4 | 2021 |
| Outcomes of participants switching from F/TDF to F/TAF for PrEP: week 48 results from the DISCOVER open label phase. C Spinner, A Avery, JA Flamm, G Crofoot, C Brinson, G Kronborg, ... Journal of the International AIDS Society 24 (S4), 29-30, 2021 | 4 | 2021 |
| Quantifying the burden of cardiovascular diseases among people living with HIV in sub-Saharan Africa: findings from a modeling study for Uganda A Kintu, D Sando, D Guwatudde, S Bahendeka, PC Kawungezi, ... Journal of Global Health Reports, 2020 | 4 | 2020 |
